Table of Contents

Experimental Studies

• Open Access

  C1orf50 Accelerates Epithelial-Mesenchymal Transition and the Cell Cycle of Hepatocellular Carcinoma

  ATSUSHI TANAKA, YUSUKE OTANI, MASAKI MAEKAWA, ANNA ROGACHEVSKAYA, TIRSO PEÑA, VANESSA D. CHIN, SHINICHI TOYOOKA, MICHAEL H. ROEHRL and ATSUSHI FUJIMURA

  Cancer Genomics & Proteomics November 2025, 22 (6) 836-849; DOI: https://doi.org/10.21873/cgp.20541
• Open Access

  Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators

  HIROKI IDE, MOHAMMAD AMIN ELAHI NAJAFI, TAKUO MATSUKAWA, TOMOYUKI TATENUMA, MOTOTSUGU OYA and HIROSHI MIYAMOTO

  Cancer Genomics & Proteomics November 2025, 22 (6) 850-862; DOI: https://doi.org/10.21873/cgp.20542
• Open Access

  Lower SYNJ2BP Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis

  MARILYN D. SAULSBURY, SIMONE O. HEYLIGER, EMANUELA TAIOLI, TAMIEL N. TURLEY, JORDAN P. REYNOLDS, JOHN A. COPLAND, ADAM M. KASE and R. RENEE REAMS

  Cancer Genomics & Proteomics November 2025, 22 (6) 863-881; DOI: https://doi.org/10.21873/cgp.20543
• Open Access

  Immunoliposome for Ewing Sarcoma

  DANIEL E. PANOSYAN, WILLIAM S. PANOSYAN, DARON S. YACOUBIAN and JOSEPH L. LASKY

  Cancer Genomics & Proteomics November 2025, 22 (6) 882-887; DOI: https://doi.org/10.21873/cgp.20544
• Open Access

  Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma

  MAREK KASIK, ROBERT ILIEV, PETRA VYCHYTILOVA, SILVIA RYBECKA, LENKA RADOVA, MICHAL STANIK, MICHAL FEDORKO, JAN DOLEZEL, ONDREJ SLABY and JULIA BOHOSOVA

  Cancer Genomics & Proteomics November 2025, 22 (6) 888-899; DOI: https://doi.org/10.21873/cgp.20545
• Open Access

  BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells

  KATHARINA WERT, JOHANNA JENTSCH, JULIA GALLWAS and CARSTEN GRÜNDKER

  Cancer Genomics & Proteomics November 2025, 22 (6) 900-911; DOI: https://doi.org/10.21873/cgp.20546
• Open Access

  Differential Proteomic Analysis of DEN-induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Sex-Specific Markers

  SALMMA SALAMAH SALIHAH, MUHAMMAD TAHIR, BAREERA BIBI, RABIA SULTAN, MARTIN R. LARSEN, MUNAZZA RAZA MIRZA, SANA MAHMOOD, MUHAMMAD RIZWAN ALAM, JAMILA IQBAL, WILLIAM C. CHO and ASMA GUL

  Cancer Genomics & Proteomics November 2025, 22 (6) 912-928; DOI: https://doi.org/10.21873/cgp.20540
• Open Access

  Global Profiling of Lysine Lactylation in Prostate Cancer Cells

  JAE YONG KIM, HYUNCHAE SIM, ANN-YAE NA, SO YOUNG CHOI and SANGKYU LEE

  Cancer Genomics & Proteomics November 2025, 22 (6) 929-939; DOI: https://doi.org/10.21873/cgp.20547
• Open Access

  Lipid Metabolic Reprogramming During Progression to Castration-resistant Prostate Cancer Identified by Quantitative Proteomics

  HYUNCHAE SIM, SUBIN BAE, CHAI WON PARK, SO YOUNG CHOI, KWANG-HYEON LIU, EUN HYE LEE, BUM SOO KIM, JAE-WOOK CHUNG, YUN-SOK HA, JUN NYUNG LEE, WONHWA LEE, TAE GYUN KWON and SANGKYU LEE

  Cancer Genomics & Proteomics November 2025, 22 (6) 940-952; DOI: https://doi.org/10.21873/cgp.20548
• Open Access

  SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer

  WEI-LUN HUANG, PEI-FANG HSIEH, SIH-HAN CHEN, RICHARD CHEN-YU WU, HSING-CHA MAI, CHUN-HSIEN WU, SEE-TONG PANG, YU-LIN YANG and VICTOR CHIA-HSIANG LIN

  Cancer Genomics & Proteomics November 2025, 22 (6) 953-970; DOI: https://doi.org/10.21873/cgp.20549
• Open Access

  Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells

  SIH-HAN CHEN, RICHARD C. WU, WEI-LUN HUANG, CHUN-HSIEN WU, HSING-CHIA MAI, YU-LIN YANG, PEI-FANG HSIEH, VICTOR C. LIN and CHIEN-HUI OU

  Cancer Genomics & Proteomics November 2025, 22 (6) 971-990; DOI: https://doi.org/10.21873/cgp.20550
• Open Access

  Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation Therapy

  YEI-TSUNG CHEN, PIN-YI CHEN, CHI-FEN CHANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, HAO-HAN CHANG, TE-LING LU, SHU-PIN HUANG and BO-YING BAO

  Cancer Genomics & Proteomics November 2025, 22 (6) 991-1005; DOI: https://doi.org/10.21873/cgp.20551
• Open Access

  Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study

  MD NAYAB SULAIMANI, PRITHVI SINGH, MOHAMMAD UMAR SAEED, SOBIA ZAIDI, AFZAL HUSSAIN, MOHAMED F. ALAJMI, ANAS SHAMSI, RAVINS DOHARE and MD IMTAIYAZ HASSAN

  Cancer Genomics & Proteomics November 2025, 22 (6) 1006-1024; DOI: https://doi.org/10.21873/cgp.20552
• Open Access

  Oxysterol-binding Protein-like 3 Promotes Tumor Progression by Regulating Apoptosis and Angiogenesis in Colorectal Cancer

  CHAN-MUK IM, HYUNG-HOON OH, SUN-YOUNG PARK, YOUNG-LAN PARK, JAE-SUNG KIM and YOUNG-EUN JOO

  Cancer Genomics & Proteomics November 2025, 22 (6) 1025-1043; DOI: https://doi.org/10.21873/cgp.20553
• Open Access

  Verbascoside Suppresses Epithelial–Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer

  HSING-CHIA MAI, PEI-FANG HSIEH, CHUN-HSIEN WU, RICHARD C. WU, SIH-HAN CHEN, WEI-LUN HUANG, MU-CHIAO TUNG, YU-LIN YANG, VICTOR C. LIN and CHIANG-TING WANG

  Cancer Genomics & Proteomics November 2025, 22 (6) 1044-1060; DOI: https://doi.org/10.21873/cgp.20554